Healthcare -
Biotechnology - NASDAQ - US
$ 6.195
-13.2 %
$ 974 M
Market Cap
-4.8
P/E
OCUL - OPERATING EXPENSES
Operating Expenses OCUL - Ocular Therapeutix, Inc.
136 M
LAST VALUE
7.56%
2 YEAR CAGR
17.45%
5 YEAR CAGR
26.51%
10 YEAR CAGR